Synthetic Biologics awarded new patent

Synthetic Biologics (SYN) gets patent 8,658,627 entitled Pregnancy Hormone Combination for Treatment of Autoimmune Diseases. The patent includes claims to the use of Trimesta (oral estriol) in conjunction with gestagen for the treatment of MS and other autoimmune diseases.

The company currently holds two other patents (8,372,826 and 6,936,599) covering the use of Trimesta.

17 mutual funds have positions in the stock, up from 9 a year earlier.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs